[1] 王登风,胡丽娜.宫颈癌的预防研究进展[J].肿瘤预防与治疗,2008,21(4):349-352.
[2] THERASSE P,ARBUCK S G,EISENHAUER E A,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J].J Natl Cancer Inst,2000,92(3):205-216.
[3] KATSAROS D,GRIBAUDO S.The proper use of multimodality treatment in locally advanced cervical cancer[J].Gynecol Oncol,2011,121(2):422-423.
[4] 孙建衡.妇科恶性肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2002:108-109.
[5] MIZUNO K,KIDOKORO K,MIYAZAKI K,et al.Neoadjuvant chemotherapy with intra arterial infusion in the treatment of advanced cervical cancer[J].Gan To Kagaku Ryoho,2005,32(6):815-819.
[6] SELVAGGI L,LOIZZI V,di GILIO A R,et al.Neoadjuvant chemotherapy in cervical cancer:a 67 patients experience[J].Int J Gynecol Cancer,2006,16(2):631-637.
[7] 糜若然,陈星.宫颈癌新辅助化疗的评价[J].国外医学:妇产科学分册,2006,33(1):61-63.
[8] 马荣,陈曦海,耿晓星,等.术前同期放化疗对局部晚期宫颈癌近期疗效的综合评价[J].实用肿瘤学杂志,2012,26(4):314-318.
[9] 张立英,曹文淼,陈立凌,等.调强适形放疗同步紫杉醇加卡铂与同步单药顺铂方案治疗晚期宫颈鳞癌的比较研究[J].东南大学学报:医学版,2012,31(4):456-459.
[10] KIM H S,KIM J Y,PARK N H,et al.Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stageⅠB1-ⅡA cervical cancer[J].Gynecol Oncol,2012,119(2):217-224. |